Nausea and Hepatocellular carcinoma

Summary:

Hepatocellular carcinoma is found among people with Nausea, especially for people who are male, 50-59 old.

The study analyzes which people have Hepatocellular carcinoma with Nausea. It is created by eHealthMe based on reports of 29 people who have Nausea from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Nausea?

Nausea (feeling of having an urge to vomit) is found to be associated with 3,883 drugs and 5,634 conditions by eHealthMe. Check the latest studies of Nausea.

What is Hepatocellular carcinoma?

Hepatocellular carcinoma (liver cancer) is found to be associated with 306 drugs and 731 conditions by eHealthMe. Check the latest studies of Hepatocellular carcinoma.

On Jul, 20, 2026

29 people who have Nausea and Hepatocellular Carcinoma are studied.

Would you have Hepatocellular carcinoma when you have Nausea?

Gender of people who have Nausea and experienced Hepatocellular Carcinoma *:

female: 24.14 %
male: 75.86 %

Age of people who have Nausea and experienced Hepatocellular Carcinoma *:

Common co-existing conditions for these people *:

Pain: 18 people, 62.07%
Stress And Anxiety: 8 people, 27.59%
High Blood Pressure: 8 people, 27.59%
Hepatitis C: 7 people, 24.14%
Nausea And Vomiting: 6 people, 20.69%
Diarrhea: 6 people, 20.69%
Urination - Excessive Volume: 5 people, 17.24%
Anaemia (lack of blood): 5 people, 17.24%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 17.24%
Hepatitis B: 4 people, 13.79%

Common drugs taken by these people *:

Common symptoms for these people *:

Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 5 people, 17.24%
Metastases To Bone (cancer spreads to bone): 5 people, 17.24%
Abdominal Pain: 4 people, 13.79%
Weight Decreased: 4 people, 13.79%
Fatigue (feeling of tiredness): 4 people, 13.79%
Therapeutic Embolisation: 4 people, 13.79%
Back Pain: 4 people, 13.79%
Disease Progression: 3 people, 10.34%
Portal Hypertensive Gastropathy (changes in the mucosa of the stomach in patients with portal hypertension;): 3 people, 10.34%
Constipation: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hepatocellular carcinoma?

- Check whether Hepatocellular carcinoma is associated with a drug or a condition

Related publications that referenced our studies

Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .

Related studies:

Treatments, associated drugs and conditions:

Nausea (962,089 reports)
Hepatocellular carcinoma (32,153 reports)

All the drugs that are associated with Hepatocellular carcinoma:

Hepatocellular carcinoma (306 drugs)

All the conditions that are associated with Hepatocellular carcinoma:

Hepatocellular carcinoma (731 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hepatocellular carcinoma and Nausea, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.